Search research articles
Contact Us
Filters
Showing results (1-10 of 37) with videos related to
Page
of 4
Sort By:
Journal of Veterinary Pharmacology and Therapeutics
|
June 8, 2011
ABCG2 transporter: therapeutic and physiologic implications in veterinary species
K L Mealey
Journal of the American Veterinary Medical Association
|
June 22, 2001
Penicillins and beta-lactamase inhibitor combinations
K L Mealey
Journal of Veterinary Pharmacology and Therapeutics
|
October 27, 2004
Therapeutic implications of the MDR-1 gene
K L Mealey
The Journal of Small Animal Practice
|
February 4, 2026
A mini-review of chronic suppression of the hypothalamic-pituitary-adrenal axis in animals with P-glycoprotein deficiency
K L Mealey
Journal of Veterinary Internal Medicine
|
January 27, 2015
P-glycoprotein mediated drug interactions in animals and humans with cancer
K L Mealey, J Fidel
Journal of the American Veterinary Medical Association
|
June 15, 1994
Nephrotoxicosis associated with topical administration of gentamicin in a cat
K L Mealey, D M Boothe
Veterinary and Comparative Oncology
|
April 22, 2009
Sequence and structural analysis of the presumed downstream promoter of the canine mdr1 gene
K L Mealey, S A Bentjen
Journal of Veterinary Pharmacology and Therapeutics
|
February 10, 2015
Identification of a nonsense mutation in feline ABCB1
K L Mealey, N S Burke
Journal of Veterinary Pharmacology and Therapeutics
|
August 13, 2004
Frequency of the mutant MDR1 allele associated with multidrug sensitivity in a sample of collies from France
C Hugnet, S A Bentjen, K L Mealey
Journal of Veterinary Pharmacology and Therapeutics
|
January 18, 2017
Establishment of a cell line for assessing drugs as canine P-glycoprotein substrates: proof of principle
K L Mealey, S Dassanayake, N S Burke
Page
of 4
Search research articles
Search
Showing results (1-10 of 37) with videos related to
Sort By:
Page
of 4
Journal of Veterinary Pharmacology and Therapeutics
|
June 8, 2011
ABCG2 transporter: therapeutic and physiologic implications in veterinary species
K L Mealey
Journal of the American Veterinary Medical Association
|
June 22, 2001
Penicillins and beta-lactamase inhibitor combinations
K L Mealey
Journal of Veterinary Pharmacology and Therapeutics
|
October 27, 2004
Therapeutic implications of the MDR-1 gene
K L Mealey
The Journal of Small Animal Practice
|
February 4, 2026
A mini-review of chronic suppression of the hypothalamic-pituitary-adrenal axis in animals with P-glycoprotein deficiency
K L Mealey
Journal of Veterinary Internal Medicine
|
January 27, 2015
P-glycoprotein mediated drug interactions in animals and humans with cancer
K L Mealey, J Fidel
Journal of the American Veterinary Medical Association
|
June 15, 1994
Nephrotoxicosis associated with topical administration of gentamicin in a cat
K L Mealey, D M Boothe
Veterinary and Comparative Oncology
|
April 22, 2009
Sequence and structural analysis of the presumed downstream promoter of the canine mdr1 gene
K L Mealey, S A Bentjen
Journal of Veterinary Pharmacology and Therapeutics
|
February 10, 2015
Identification of a nonsense mutation in feline ABCB1
K L Mealey, N S Burke
Journal of Veterinary Pharmacology and Therapeutics
|
August 13, 2004
Frequency of the mutant MDR1 allele associated with multidrug sensitivity in a sample of collies from France
C Hugnet, S A Bentjen, K L Mealey
Journal of Veterinary Pharmacology and Therapeutics
|
January 18, 2017
Establishment of a cell line for assessing drugs as canine P-glycoprotein substrates: proof of principle
K L Mealey, S Dassanayake, N S Burke
Page
of 4